InMode (INMD) Depreciation and Depletion (2024 - 2025)

InMode (INMD) posted quarterly Depreciation and Depletion of $174000.0 for Q4 2025, down 29.84% year-on-year from $248000.0 in Q4 2024, and down 29.84% on a QoQ basis from $248000.0 in Q4 2024.

InMode (INMD) Depreciation and Depletion (2024 - 2025) Analysis & Trends

InMode (INMD) has reported Depreciation and Depletion for 2 consecutive years, with $174000.0 the latest figure, recorded in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 308.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 89.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InMode 956,721.10 -479.17 Mn 61.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 174,000.00
Dec 31, 2025 174,000.00
Dec 31, 2024 248,000.00
Dec 31, 2024 248,000.00